Resultados financieros en millones de dólares estadounidenses. El ejercicio fiscal es febrero - enero.
Breakdown
TTM
04/30/2025
04/30/2024
04/30/2023
04/30/2022
04/30/2021
Ingresos
17,567
18,016
18,119
16,869
14,548
13,763
Crecimiento de los Ingresos (YoY)
-1%
-1%
7%
16%
6%
-6%
Costo de los ingresos
10,862
11,206
11,316
10,449
9,111
8,153
Utilidad bruta
6,705
6,810
6,803
6,420
5,437
5,610
Venta, General y Administración
3,011
2,545
2,479
2,381
2,122
1,842
Investigación y Desarrollo
27
-1,150
830
840
840
765
Gastos de Operación
4,888
4,795
4,436
4,243
3,949
3,801
Otras Ingresos (Gastos) No Operativos
--
-186
-157
-114
-54
-61
Ingreso antes de impuestos
570
490
1,668
1,198
1,501
1,630
Gasto por Impuesto a la Renta
281
250
365
254
345
377
Ingreso Neto
292
237
1,302
943
1,154
1,254
Crecimiento de la Utilidad Neta
-71%
-82%
38%
-18%
-8%
16%
Acciones en Circulación (Diluidas)
382.08
382.13
382.08
382.36
382.08
382.08
Cambio de Acciones (YoY)
0%
0%
0%
0%
0%
0%
EPS (Diluido)
0.76
0.62
3.4
2.46
3.02
3.28
Crecimiento de EPS
-71%
-82%
38%
-18%
-8%
16%
Flujo de efectivo libre
1,975
1,056
817
400
450
1,706
Flujo de efectivo libre por acción
--
--
--
--
--
--
Margen bruto
38.16%
37.79%
37.54%
38.05%
37.37%
40.76%
Margen de operación
10.34%
11.18%
13.06%
12.9%
10.22%
13.14%
Margen de beneficio
1.66%
1.31%
7.18%
5.59%
7.93%
9.11%
Margen de flujo de caja libre
11.24%
5.86%
4.5%
2.37%
3.09%
12.39%
EBITDA
3,105
3,314
3,503
3,239
2,527
3,013
Margen de EBITDA
17.67%
18.39%
19.33%
19.2%
17.37%
21.89%
D&A para EBITDA
1,288
1,299
1,136
1,062
1,039
1,204
EBIT
1,817
2,015
2,367
2,177
1,488
1,809
Margen de EBIT
10.34%
11.18%
13.06%
12.9%
10.22%
13.14%
Tasa de Impuesto Efectiva
49.29%
51.02%
21.88%
21.2%
22.98%
23.12%
Estadísticas clave
Cierre Anterior
$6.15
Precio de apertura
$6.14
Rango del día
$6.14 - $6.14
Rango de 52 semanas
$4.35 - $6.93
Volumen
406
Volumen promedio
6.0K
EPS (TTM)
0.08
Rendimiento de dividendos
--
Cap. de mercado
$2.2B
¿Qué es EKTAY?
Elekta AB is a medical technology company, which engages in the provision of clinical solutions for the treatment of cancers and brain disorders. The company is headquartered in Stockholm, Stockholm and currently employs 4,484 full-time employees. The firm offers and develops systems for radiation therapy and radio-surgery, as well as software systems that enhance workflow efficiency throughout the entire spectrum of cancer care. Elekta AB (publ) develops clinical treatment solutions for radiation therapy and radiosurgery, as well as work flow-enhancing software systems, across the spectrum of cancer care. The firm provides clinical solutions for image guided radiation therapy and stereotactic radiosurgery, giving oncologists and neurosurgeons an unmatched capability to treat tumors and functional targets with ultra-high precision while sparing healthy tissue.